|
You are here:
Education & Tools
>
|
|
 |
 Conference Highlights |
Antifungal Susceptibility
-
ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA SPP. ISOLATED FROM PEDIATRIC PATIENTS: A SURVEY OF FOUR CHILDREN'S HOSPITALS
Foraker E1, Zaoutis TE2, Levin S1,
McGowan KL2, Mortensen J3, Campos J4, Klein JD5
1The Infectious Disease Laboratory, Christiana Care Health Services, Wilmington, USA
2The Children's Hospital of Philadelphia, Philadelphia, USA
3Cincinnati Children's Hospital Medical Center, Cincinnati, USA
-
ACTIVITY OF ANIDULAFUNGIN AGAINST CANDIDA ISOLATES FROM FIVE EUROPEAN COUNTRIES
Johnson EM, 1 Goldstein BP, 2 Davey KG, 1 Fraser MA 1
1HPA Mycology Reference Laboratory, Kingsdown, UK
2Vicuron Pharmaceuticals, King of Prussia, USA
-
EFFECT OF CONCENTRATION EXCEEDING MICS OF ANTIFUNGAL AGENTS ON THE SELECTION OF RESISTANT MUTANTS OF CANDIDA SPP. AND CRYPTOCOCCUS NEOFORMANS.
Nguyen K, Arora D, Nguyen MH, Clancy CJ
University of Florida College of Medicine, Gainesville, USA
-
In Vitro Activities of Three New Triazoles (Voriconazole, Posaconazole And Ravuconazole) Compared with Fluconazole and Itraconazole against Candida glabrata Species
Paritpokee S, Isada CM, Bernard H, Warner DK, Procop GW, Hall GS
The Cleveland Clinic Foundation, Cleveland, USA
-
ACQUIRED RESISTANCE AND REVERSIBILITY OF ASPERGILLUS FUMIGATUS TO ITRACONAZOLE
Chen J, Wan Z, Li R.
Peking University First Hospital, Research Center for Medical Mycology, Peking University, Beijing, China
-
EXTRA COPIES OF THE ASPERGILLUS FUMIGATUS SQUALENE EPOXIDASE GENE CONFER RESISTANCE TO TERBINAFINE: A GENETIC APPROACH TO STUDY GENE-DOSE DEPENDENT RESISTANCE TO ANTIFUNGALS IN ASPERGILLUS FUMIGATUS
Kontoyiannis DP1, Liu W1, May GS2
1Department of Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, USA
2Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, USA
-
INVESTIGATION OF ASSOCIATION OF HETERORESISTANCE TO FLUCONAZOLE (FCZ) IN C, NEOFORMANS MENINGITIS (CM), DEVELOPMENT OF RESISTANCE (R) AND FAILURE OF THERAPY (RX)
Stevens DA, McCullough MJ, Espiritu M, Parmar R
Sta. Clara Valley Med. Ctr., Stanford Univ., Calif. Inst. For Med. Research; San Jose and Stanford, USA
|
|